On the other hand, LIV-1 expression may also be stimulated by growth factors in the tumor microenvironment, since treatment with TGFα, TGF-β1, EGF, IGF-1 and β2-M all enhanced the LIV-1 level [3], [4], [27]. The gene discussed is SLC39A6; the disease is neoplasm.